Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study

Table 4 Summary of AEs and their relation to DSG treatment, outcome

		Number of AE records	Number of patients
		n	n
Total AE		329	21
Type of AE	Infections and infestations	59	18
	Gastrointestinal disorders	52	16
	General disorders/administration site condition	39	17
Intensity	Mild	218	21
	Moderate	90	18
	Severe	17	7
Outcome	Resolved	221	21
	Additional therapy	81	16
	Hospitalization	14	7
	Premature termination	8	5
Relationship to DSG	No	156	20
	Unlikely	42	15
	Possibly	86	18
	Probably	37	13
	Definitely	6	4

ISSN: 1478-6362